Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe toxicity of Gemini-Cur on HT-29 and HCT116 was studied through MTT, uptake kinetics, fluorescence microscopy, annexin V/FITC, and cell cycle assays.
[International Journal of Pharmaceutics]
6445212 {6445212:BHBS3TEA} apa 50 1 161496 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-ed8eb0212bc033cc5b9fa37f6f05c2ec%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BHBS3TEA%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ebrahimi%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EEbrahimi%2C%20M.%2C%20Babaei%2C%20E.%2C%20Neri%2C%20F.%2C%20%26amp%3B%20Feizi%2C%20M.%20A.%20H.%20%282021%29.%20Anti-proliferative%20and%20apoptotic%20effect%20of%20gemini%20curcumin%20in%20p53-wild%20type%20and%20p53-mutant%20colorectal%20cancer%20cell%20lines.%20%3Ci%3EInternational%20Journal%20of%20Pharmaceutics%3C%5C%2Fi%3E%2C%20%3Ci%3E601%3C%5C%2Fi%3E%2C%20120592.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijpharm.2021.120592%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijpharm.2021.120592%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DBHBS3TEA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-proliferative%20and%20apoptotic%20effect%20of%20gemini%20curcumin%20in%20p53-wild%20type%20and%20p53-mutant%20colorectal%20cancer%20cell%20lines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masoumeh%22%2C%22lastName%22%3A%22Ebrahimi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esmaeil%22%2C%22lastName%22%3A%22Babaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Neri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%20Ali%20Hosseinpour%22%2C%22lastName%22%3A%22Feizi%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnDespite%20recent%20advances%20in%20therapy%2C%20colorectal%20cancer%20remains%20a%20leading%20cause%20of%20death%20in%20affected%20people.%20Curcumin%20is%20the%20main%20bioactive%20compound%20of%20turmeric%20that%20has%20been%20demonstrated%20as%20an%20effective%20agent%20against%20cancer.%20However%2C%20its%20poor%20stability%20and%20bioavailability%20limit%20therapeutic%20application.%20We%20previously%20showed%20that%20delivery%20of%20curcumin%20by%20using%20gemini%20surfactant%20nanoparticles%20called%20gemini%20curcumin%20%28Gemini-Cur%29%20could%20improve%20its%20solubility%2C%20uptake%20and%20toxic%20effect%20on%20breast%20and%20ovarian%20cancer%20cells.%20Here%2C%20we%20aimed%20to%20investigate%20the%20anticancer%20activity%20of%20Gemini-Cur%20in%20both%20p53-mutant%20and%20p53-wild%20type%20colorectal%20cancer%20cells.%20The%20toxicity%20of%20Gemini-Cur%20on%20HT-29%20and%20HCT116%20was%20studied%20through%20MTT%2C%20uptake%20kinetics%2C%20fluorescence%20microscopy%2C%20annexin%20V%5C%2FFITC%2C%20and%20cell%20cycle%20assays.%20Also%2C%20real-time%20PCR%20and%20western%20blotting%20were%20performed%20to%20evaluate%20the%20expression%20of%20p53%2C%20p21%2C%20BAX%2C%20BCL-2%2C%20and%20NOXA%20genes.%20Our%20data%20showed%20that%20Gemini-Cur%20not%20only%20enters%20cells%20quite%20rapidly%20compared%20to%20free%20curcumin%20crystals%2C%20but%20also%20suppresses%20HT-29%20and%20HCT-116%20cells%20proliferation%20in%20a%20time-%20and%20dose-dependent%20manner%20%28p%5Cu00a0%3C%5Cu00a00.001%29.%20The%20IC50%20values%20as%20well%20as%20apoptosis%20assays%20showed%20that%20p53-wild%20type%20cells%20are%20sensitive%20to%20Gemini-Cur.%20Flow%20cytometry%20also%20revealed%20that%20the%20number%20of%20apoptotic%20cells%20is%20dramatically%20increased%20in%20HCT-116%20cells%20earlier%20than%20HT-29%20cells%20%28p%5Cu00a0%3C%5Cu00a00.0001%29.%20Gemini-Cur%20upregulated%20apoptotic%20genes%20including%20p53%20%28in%20both%20mutant%20and%20wild-type%20forms%29%2C%20p21%2C%20NOXA%20and%20BAX%20while%20decreased%20anti-apoptotic%20BCL-2%20in%20mRNA%20and%20protein%20level%20%28p%5Cu00a0%3C%5Cu00a00.0001%29.%20As%20a%20hallmark%20of%20apoptosis%2C%20the%20expression%20ratio%20of%20BAX%5C%2FBCL-2%20was%20significantly%20increased%20in%20all%20treated%20cells.%20Taken%20together%2C%20our%20findings%20demonstrated%20that%20Gemini-Cur%20suppresses%20the%20proliferation%20of%20cancer%20cells%20via%20induction%20of%20apoptosis%20and%20could%20be%20considered%20as%20novel%20nano-formulated%20phytochemical%20for%20cancer%20targeting.%22%2C%22date%22%3A%22May%2015%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijpharm.2021.120592%22%2C%22ISSN%22%3A%220378-5173%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0378517321003975%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-23T17%3A40%3A13Z%22%7D%7D%5D%7D
Ebrahimi, M., Babaei, E., Neri, F., & Feizi, M. A. H. (2021). Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines. International Journal of Pharmaceutics, 601, 120592. https://doi.org/10.1016/j.ijpharm.2021.120592 Cite
